Tatas to focus on metabolism, diabetes drugs
Sify - Chennai,Tamil Nadu,India
After making significant progress in the field, it has zeroed in on two segments — diabetes and metabolic disorders. Kishore A Chaukar, the managing ...
Western European Diabetes Market Shows Movement to Exclusive Pill ...
MarketWatch -
And while the proportion of patients receiving no medication continues to decline, the use of insulin within the diabetes population remains relatively ...
Reliable test to spot pre-diabetes developed
Thaindian.com -
Lead researcher Gerald Hart says that early stages of the disease, scientifically known as “pre-diabetes”, are characterised by increased reaction rates ...
Diabetes Australia calls for Olympic funding match
ABC Online -
The Federal Government has been urged to match any new Olympic sports funding with money to combat the spread of diabetes. The call from Diabetes
Study backs low vitamin D-diabetes link
Reuters India -
Study links diabetes with caesarean sections
NEWS.com.au -
Picture: James Elsby BABIES delivered by caesarean section could have a 20 per cent higher risk of developing Type 1 diabetes compared to those born ...
Cellular research holds promise for diabetes
Honolulu Star-Bulletin -
... blood sugar levels fell to near-normal. The study's senior researcher has strong motivation to seek new treatment. His children have Type 1 diabetes.
Coronary Artery Revascularization in Diabetes Trial (CARDia ...
Cardiosource - Washington,DC,USA
About 31% of the patients were on insulin, and the mean duration of diabetes was about 10.2 years, with a mean glycated hemoglobin of about 7.9%. ...
Diamyd's NTDDS Technology Found to Be Effective Against Diabetes Pain
RedOrbit - Dallas,TX,USA
Diamyd Medical's diabetes product portfolio includes NP2, Diamyd vaccine for type 1 diabetes and Diamyd vaccine for Lada. Darren Wolfe, president of Diamyd, ...
Non Controversial Biotech Breakthrough for Diabetes
By Wesley J. Smith(Wesley J. Smith)
Once again, the always false meme that embryonic stem cells are the "only chance" for treatments for diseases such as diabetes, has been proved to be utterly false--and reported by LA Times, no less: Scientists have used proteins to ...
Secondhand Smoke: Your 24/7 Bioethics... - http://www.wesleyjsmith.com/
Diamyd Medical: Diamyd Medical’s NTDDS Technology Effective ...
By admin
Diamyd Medical (Pink Sheets:DMYDY)(STO:DIAMB) reports that its Nerve Targeting Drug Delivery System (NTDDS) expressing enkephalin, is effective in preclinical models of diabetes pain. Dr. David Fink, published in the scientific journal ...
Medical Health Articles - http://google-sina.com
